Gain Therapeutics Inc at Jefferies Healthcare Conference Transcript
Thank you, [Jace], and thanks to Jefferies for organizing this great conference. It's wonderful to reconvene in person after a long period, and I'm happy to be here to present to you Gain Therapeutics and what we're up to. Let's see if it works.
We're a publicly traded company, so I will be making forward-looking statements today. There are risks about these forward-looking statements that we have described in detail in our SEC filings, so please read up on those and keep them in mind as you make investment decisions.
Gain Therapeutics is essentially focused around three areas of expertise and competence. One is the computational drug discovery platform that we have established, that our Chief Technology Officer has developed over a period of 10 years. And that we have applied to generate the entirety of our product pipeline.
The platform is particularly suited to identify novel targets, binding sites, proteins of interest that are involved in a disease, and to identify small molecule binders that then interact with these binding
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
